insights_auto
Why is GOVX down 16.42%?
Dive Deeperchevron_right
GOVX:NASDAQ
GeoVax Labs Ord Shs
$1.70
arrow_downward
-16.42%(-0.33) 1D
$1.69
arrow_downward
-0.88% (-0.015)todayPre-market
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$2.20
High
$2.20
Low
$1.57
Mkt. cap
867.41K
Avg. vol.
54.29K
Volume
5.68M
52-wk high
$300.00
52-wk low
$1.57
EPS
-$157.85
Beta
3.85
Shares outstanding
544.00K
No. of employees
19
Open
$2.20
High
$2.20
Low
$1.57
Mkt. cap
867.41K
Avg. vol.
54.29K
Volume
5.68M
52-wk high
$300.00
52-wk low
$1.57
EPS
-$157.85
Beta
3.85
Shares outstanding
544.00K
No. of employees
19
News stories
From web sources and news partners
Nieuws.nl
·
4 hours ago
AEX-index begint voorzichtig aan belangrijke week voor AI-sector
Nieuws.nl
·
3 days ago
AEX-index lager door onrust rond Nvidia
Opening Bell Daily
·
16 minutes ago
Berkshire stock: beat the S&P 500 in every dot-com bust year
Reuters
·
3 days ago
S&P 500, Nasdaq end lower as Nvidia uncertainty weighs on tech shares
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About GeoVax Labs Ord Shs
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegeovax.com